Barclays PLC Adamis Pharmaceuticals Corp Transaction History

Barclays PLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.23 $4,187 - $9,036	-7,347 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$0.92 - $1.18 $1,678 - $2,152	1,824 Added 33.03%	7,347 $8,000
Q2 2021 Aug 13, 2021	SELL	$0.66 - $1.23 $17,246 - $32,141	-26,131 Reduced 82.55%	5,523 $6,000
Q1 2021 May 13, 2021	BUY	$0.54 - $1.79 $17,093 - $56,660	31,654 New	31,654 $30,000
Q4 2019 Feb 10, 2020	SELL	$0.51 - $1.26 $55 - $137	-109 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$0.7 - $1.46 $76 - $159	109 New	109 $0
Q2 2019 Aug 14, 2019	SELL	$1.26 - $2.23 $217,421 - $384,802	-172,557 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.02 - $3.22 $250,191 - $398,819	123,857 Added 254.33%	172,557 $364,000
Q4 2018 Feb 14, 2019	BUY	$2.1 - $3.21 $102,270 - $156,327	48,700 New	48,700 $110,000
Q2 2018 Aug 14, 2018	SELL	$3.2 - $4.7 $5,440 - $7,990	-1,700 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$2.55 - $4.85 $266,069 - $506,053	-104,341 Reduced 98.4%	1,700 $6,000
Q4 2017 Feb 14, 2018	BUY	$3.5 - $5.65 $371,143 - $599,131	106,041	106,041 $466,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.